advertisement
Pulmonary Medicine
139
1-13 of 13
- FDA Drug Information Updates
FDA Review: Adding LABAs to ICS Treatment Does Not Significantly Increase Serious Asthma Outcomes Risk
- Medical Breakthroughs from Penn Medicine
A Thoracic Surgeon's Viewpoint on Screening, Diagnosis and Treatment of a Lung Cancer Patient


























































